Trial Profile
An Open-label, 2-period, drug-drug interaction study, evaluating pharmacokinetic interaction between letermovir and posaconazole in healthy female subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Apr 2018
Price :
$35
*
At a glance
- Drugs Letermovir (Primary) ; Posaconazole
- Indications Cytomegalovirus infections
- Focus Pharmacokinetics
- 26 Mar 2018 Results assessing pharmacokinetics and tolerability of letermovir coadministered with azole antifungals (posaconazole or voriconazole) in healthy subjects in two phase1 trials, were published in the journal of clinical pharmacology.
- 30 Dec 2015 New trial record